Treatment-Related Adverse Events of PD-1 and PD-L1 Inhibitors in Clinical Trials: A Systematic Review and Meta-analysis

IMPORTANCE: Programmed cell death (PD-1) and programmed cell death ligand 1 (PD-L1) inhibitors have been increasingly used in cancer therapy. Understanding the treatment-related adverse events of these drugs is critical for clinical practice. OBJECTIVE: To evaluate the incidences of treatment-relate...

詳細記述

保存先:
書誌詳細
出版年:JAMA Oncol
主要な著者: Wang, Yucai, Zhou, Shouhao, Yang, Fang, Qi, Xinyue, Wang, Xin, Guan, Xiaoxiang, Shen, Chan, Duma, Narjust, Vera Aguilera, Jesus, Chintakuntlawar, Ashish, Price, Katharine A., Molina, Julian R., Pagliaro, Lance C., Halfdanarson, Thorvardur R., Grothey, Axel, Markovic, Svetomir N., Nowakowski, Grzegorz S., Ansell, Stephen M., Wang, Michael L.
フォーマット: Artigo
言語:Inglês
出版事項: American Medical Association 2019
主題:
Original Investigation
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC6487913/
https://ncbi.nlm.nih.gov/pubmed/31021376
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jamaoncol.2019.0393
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料